It is a broadly described annual report of Dr. Reddy’s Laboratories Limited in the year of 2014-2015. During the financial year, The Company’s net revenue increased by 12% over the previous year to Rs. 148.19 billion. Earnings before interest, taxes, depreciation, and amortization (EBITDA) rose by 9% to Rs. 36.17 billion, or 24% of consolidated revenue. Profit before taxes (PBT) grew by 6% over the previous year to Rs. 28.16 billion, or US$ 452 million. Profits after tax (PAT) increased by 3% to Rs. 22.18 billion, at 15% of consolidated net revenue. Cash and cash equivalents (including other investments) rose by 18% to Rs. 39.65 billion as on 31st March 2015, or US$ 636 million.
The Board of Directors of the Company has proposed a dividend of Rs. 20 per share on equity shares of Rs. 5/- each.
More Annual Report of Dr. Reddy’s Laboratories Limited:
- Annual Report 2001-2002 of Dr. Reddy’s Laboratories Limited
- Annual Report 2002-2003 of Dr. Reddy’s Laboratories Limited
- Annual Report 2003-2004 of Dr. Reddy’s Laboratories Limited
- Annual Report 2004-2005 of Dr. Reddy’s Laboratories Limited
- Annual Report 2005-2006 of Dr. Reddy’s Laboratories Limited
- Annual Report 2006-2007 of Dr. Reddy’s Laboratories Limited
- Annual Report 2007-2008 of Dr. Reddy’s Laboratories Limited
- Annual Report 2008-2009 of Dr. Reddy’s Laboratories Limited
- Annual Report 2009-2010 of Dr. Reddy’s Laboratories Limited
- Annual Report 2010-2011 of Dr. Reddy’s Laboratories Limited
- Annual Report 2011-2012 of Dr. Reddy’s Laboratories Limited
- Annual Report 2012-2013 of Dr. Reddy’s Laboratories Limited
- Annual Report 2013-2014 of Dr. Reddy’s Laboratories Limited
- Annual Report 2014-2015 of Dr. Reddy’s Laboratories Limited
- Annual Report 2015-2016 of Dr. Reddy’s Laboratories Limited
- Annual Report 2016-2017 of Dr. Reddy’s Laboratories Limited
